Overview
Aaron Hata is an Oncologist in Boston, Massachusetts. Dr. Hata is rated as an Elite provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Hata is currently accepting new patients.
His clinical research consists of co-authoring 100 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 68 articles in the study of Lung Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
55 Fruit St, Boston, MA 02114
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The General Hospital Corporation
Justin Gainor is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Gainor is rated as an Elite provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and EGFR Positive Lung Cancer. Dr. Gainor is currently accepting new patients.
The General Hospital Corporation
Lecia Sequist is an Oncologist and a Hematologist in Waltham, Massachusetts. Dr. Sequist is rated as an Elite provider by MediFind in the treatment of Lung Cancer. Her top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy. Dr. Sequist is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Biagio Ricciuti is an Oncologist in Boston, Massachusetts. Dr. Ricciuti is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Metastatic Pleural Tumor.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung CancerDr. Hata isElite. Learn about Lung Cancer.
- Distinguished
- Non-Small Cell Lung Cancer (NSCLC)Dr. Hata isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Small Cell Lung Cancer (SCLC)Dr. Hata isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- EGFR Positive Lung CancerDr. Hata isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaDr. Hata isAdvanced. Learn about Lung Adenocarcinoma.
- Squamous Cell Lung CarcinomaDr. Hata isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Tissue BiopsyDr. Hata isAdvanced. Learn about Tissue Biopsy.
- Experienced
- MelanomaDr. Hata isExperienced. Learn about Melanoma.